Edible seaweed and kelp are a systematic Cd and As exposure pathway that conventional food-safety surveillance does not adequately characterize
Three independent A-tier datasets — a 12-site spatial-temporal survey of New Zealand kelp, a 43-site Salish Sea contaminant assessment across three commercially harvested brown seaweeds, and the EFSA CONTAM Panel’s full European-population dietary exposure assessment built on more than two thousand occurrence data points — converge on a finding the wiki must surface prominently: commercial edible seaweed and kelp products carry systematically elevated cadmium and arsenic concentrations that conventional terrestrial-food-chain surveillance frameworks do not capture, and that the certification and consumer-communication infrastructure built around terrestrial commodities does not address.
The finding is distinct from the established organoarsenical inertness synthesis, which addressed the toxicological status of organic-arsenic species in seafood, fungi, microalgae, and seaweed. That synthesis is about the assumption that organoarsenicals are biologically inert. This synthesis is about the contamination magnitude and the regulatory blind spot at the product-distribution end of the supply chain. The two synthesis pages are complementary: the inertness synthesis tells us we cannot read total arsenic minus inorganic arsenic as “the safe part”; this synthesis tells us the totals themselves are large enough that the framing question matters at population scale.
The New Zealand kelp signal (Nepper-Davidsen 2023)
Nepper-Davidsen, Glasson, Lawton, and Magnusson 2023, published in the Journal of Applied Phycology, surveyed Ecklonia radiata kelp at 12 sites across the North Island of New Zealand with 12 additional monthly temporal samples at a single reference site, total n=24 ICP-MS homogenates of six specimens each. The mean total arsenic concentration was 49 ppm dry weight (range 40.0 to 64.4 ppm DW across sites); the mean cadmium was 1.2 ppm DW (range 0.4 to 2.2 ppm); mean lead was 0.3 ppm DW with one site at 0.7 ppm; mean mercury was below 0.04 ppm DW at every site. Significant temporal autocorrelation was detected for arsenic and mercury at the reference site, meaning a single-time-point measurement at any one harvesting cycle does not characterize the annual exposure profile. Ecklonia radiata is being developed as a New Zealand aquaculture target, so the product-safety implications are direct.
The paper does not speciate arsenic. Brown algae arsenic is predominantly organoarsenic forms — arsenobetaine, arsenosugars, and arsenolipids — but the iAs fraction is not zero and the speciation-specific safety implication cannot be derived from total arsenic alone. The paper’s 49 ppm DW tAs mean is the load-bearing number for the wiki: a hypothetical 1 percent iAs fraction would deliver 490 ppb iAs DW per serving, which on a typical 5 g dried-kelp serving translates to 2.45 µg of inorganic arsenic per serving and saturates a meaningful fraction of the EFSA BMDL01 reference exposure window for an adult.
The Salish Sea signal (Hahn 2022)
Hahn et al. 2022, published in PLOS ONE, sampled three edible brown seaweed species (Fucus distichus, Macrocystis pyrifera, Nereocystis luetkeana) at 43 sites across the Salish Sea spanning coastal Washington State and southern British Columbia, n=58 ICP-MS samples. The headline finding: cadmium exceeded international regulatory limits at every site for at least one species, with bull kelp (Nereocystis luetkeana) mean Cd 5.69 mg/kg DW. Fucus distichus mean Cd was 2.52 mg/kg DW; tAs mean was 26.8 mg/kg DW with sites reaching 37 mg/kg. The maximum Pb spike was 13.2 mg/kg DW at an industrial-adjacent site, indicating that recreational-harvest sites near coastal industrial infrastructure inherit additional point-source Pb on top of the systematic Cd and As load.
The Salish Sea is a temperate, industrialized coastline with a long history of indigenous, recreational, and increasingly commercial seaweed harvest. The site-uniformity of the Cd exceedance is the load-bearing observation: the contamination is not site-specific in the sense of one bad bay versus several clean ones; the regional-scale baseline itself exceeds international consumption-safety limits for Cd, across all 43 sites and across all three species. The authors conclude explicitly that current international standards may be inadequate to protect frequent consumers of locally harvested seaweed.
The EFSA regulatory anchor (EFSA 2023)
EFSA CONTAM Panel 2023 is the definitive EU-level scientific opinion on heavy metals in seaweeds and halophytes as food. The opinion analyzed 2,093 Cd occurrence data points, 1,988 Pb, 1,934 tAs, 920 iAs, and 1,499 tHg data points across the seaweed species relevant to European food markets, including laver, kombu, kelp, nori, spirulina, and chlorella. Laver red algae exhibited the highest Cd, reaching 1,675 to 1,676 µg/kg on a wet-weight basis (which translates upward by roughly an order of magnitude on a dry-weight basis as consumed in dried seaweed products). Kombu and kelp had among the highest iAs concentrations of any food matrix in the EU dataset.
The opinion concludes that seaweed consumption — particularly Asian-style dried seaweed products and seaweed-containing food supplements — is a meaningful contributor to dietary heavy-metal exposure for European consumers, with the iAs contribution from seaweed food supplements potentially approaching or exceeding the BMDL01 for some high-consumption scenarios. EFSA’s framing is the regulatory anchor the wiki position needs: this is not a contested or emerging finding; the EU’s contaminants panel has formally assessed it and concluded that the existing regulatory framework does not adequately characterize the exposure pathway.
The mechanistic explanation
Seaweeds and kelps are biological accumulators of trace elements from the seawater they grow in. Brown algae in particular bind cadmium through algal-cell-wall alginate polysaccharides; the chemical mechanism is durable across species and ocean basins. Arsenic accumulation in brown algae is dominated by uptake into arsenosugars and arsenolipids via the same metabolic pathways that handle phosphate; arsenic is metabolized into stable organic forms but is not excluded from accumulation. The two metals therefore co-elevate in commercial brown-algae products through fundamental biology, not through localized contamination, and the elevation tracks ocean concentrations rather than agricultural or processing-side drivers.
This is mechanistically distinct from terrestrial food contamination. A rice plant grown in low-Cd soil produces low-Cd rice; an apple from a clean orchard is low in Pb. A kelp specimen grown in a clean coastal site is not low in Cd. The accumulation factor for brown algae from typical coastal seawater Cd (low ng/L) to product (mg/kg DW) is roughly 10⁵ to 10⁶; even nominally clean ocean water delivers enough Cd to push the biological tissue concentration above terrestrial-commodity regulatory limits. Cadmium contamination in seaweed is a biological feature of the product class, not a quality-control failure.
For lead, the picture is different. Lead is not bioaccumulated by brown algae through a comparable high-affinity pathway, so background Pb in commercial seaweed is generally low and the elevated values (such as the 13.2 mg/kg Salish Sea site in Hahn 2022) reflect proximity to point-source Pb deposition (industrial outflow, antifouling paint, harbor sediment). The Pb risk in seaweed is therefore a sourcing-and-screening problem in the conventional sense; the Cd and As risks are not.
Why conventional food surveillance has missed this
Conventional food-safety surveillance frameworks are built around terrestrial commodity matrices: cereals, fruit, vegetables, meat, dairy, fish. Seaweed enters most national food databases either as a minor entry in the “other algae” category or not at all. The 2,093-record EFSA dataset is the result of the panel pulling occurrence data from many specialized sources rather than a routine national-monitoring stream. The USDA FoodData Central database does not list seaweed-specific heavy-metal occurrence in any structured form. The FDA Total Diet Study has minimal seaweed coverage.
The consequence is that brands selling dried seaweed snacks, kelp supplements, spirulina powders, and seaweed-containing meal-replacement products operate in a category where the contamination magnitudes are large, the regulatory limits are inconsistently applied across jurisdictions, and the consumer assumption is generally that “sea vegetable” is a healthy minimally-processed food. The category combines a high-magnitude contamination problem with a low-surveillance signal and a positive consumer perception. That combination is the structural condition under which a class-action attack surface develops.
The strategic implications
For the brand-legal audience: any brand marketing seaweed, kelp, laver, kombu, nori, or sea-vegetable-derived ingredients into US, EU, UK, or AU markets should expect a class-action defense to require independent Cd and iAs (not tAs) lot-level testing as standard due diligence. The three-source preponderance documented here, the EFSA regulatory positioning, and the biological-feature nature of the Cd contamination together make the “we did not know” defense unavailable. Brands operating in this category that are not testing on the EFSA-monitored analyte set are accepting a level of exposure that the literature does not support as reasonable.
For the regulator audience: the EU has a formal CONTAM opinion on seaweed; the US FDA has guidance on iAs in rice cereal but no comparable seaweed-specific limit-setting in force. The regulatory asymmetry is itself a load-bearing finding. US-market seaweed-snack and kelp-supplement products are sold under a framework where the iAs and Cd content is unconstrained by any federal product-specific limit; state-level Prop 65 enforcement is the only operative pressure, and that operates through a different mechanism than the FDA Closer to Zero or EU 2023/915 frameworks. The case for harmonized seaweed-specific limit-setting in the US is supported by the present synthesis.
For the consumer audience: seaweed and kelp products are not low-heavy-metal foods. The wiki position should be that consumers concerned about heavy-metal exposure should treat seaweed-containing products as a meaningful contributor to Cd and iAs intake, that brands marketing seaweed as a “superfood” or “sea vegetable” without disclosing heavy-metal content are operating against the available evidence, and that occurrence-tested certification (HMTc) is the operative quality signal in this category because organic certification (per organic-certification-not-protective) does not address the contamination mechanism here either.
For HMTc: seaweed and kelp are a category where HMTc certification adds load-bearing safety information that no other certification scheme on the market currently provides. The product-category pages seaweed-snacks, dietary-supplements (kelp-containing subset), and any future seaweed-meal-replacement should be developed as HMTc-priority categories with Cd, iAs, and Pb as the operative analytes and tAs as the speciation prerequisite metric. The Path A literature anchors for the seaweed HMTc standard are the three sources above plus the broader EFSA dataset.
What this synthesis does not yet rest on
A US-specific FDA-equivalent occurrence dataset for the US retail market is not in the corpus. The Hahn 2022 Salish Sea dataset is the closest US-relevant anchor but represents harvested-from-coast biological material rather than commercial-retail product. A US retail-market survey across the major commercial seaweed-snack and kelp-supplement product lines would strengthen the brand-legal positioning meaningfully and is a candidate for a Journal of Food Metallomics paper.
Spirulina and chlorella are mentioned in the EFSA dataset and warrant their own treatment. They are biologically distinct from brown-algae kelp (spirulina is a cyanobacterium; chlorella is a green microalga) and the contamination mechanism for As in microalgae is different from the brown-algae mechanism described here. The organoarsenical-inertness-assumption page covers the speciation question for microalgae; the magnitude question for spirulina and chlorella Cd is not yet synthesized.
Iodine, which is the other major safety concern for kelp consumption (high iodine can cause thyroid dysfunction), is outside the scope of this synthesis but warrants a parallel page if iodine becomes part of the wiki’s analyte vocabulary. The EFSA 2023 opinion covers iodine as part of the same scientific opinion.
The Cd-bioaccumulation magnitude across non-brown-algae species (red algae such as nori and laver, green algae such as sea lettuce) is documented in EFSA 2023 but not yet broken out into species-specific source pages for the wiki. A targeted ingest pass on species-level seaweed Cd literature would strengthen the per-species component of the ingredient pages.
Implications for downstream wiki pages
seaweed should be developed with this synthesis as the load-bearing reference for the Cd and tAs profile, with the EFSA 2023 numbers as the regulatory anchor. The page should distinguish brown algae (high Cd, high tAs), red algae (highest Cd in laver), and green algae (variable) explicitly.
kelp, laver, kombu, wakame, and nori should each carry their species-specific contamination profile when stub pages are created or upgraded.
seaweed-snacks should be developed as an HMTc-priority product category with this synthesis as the literature anchor for threshold-setting work.
dietary-supplements should carry a subsection on kelp-supplement Cd and iAs as a distinct risk pathway within the supplement category, separate from the organic certification null finding and from the spice-adulteration synthesis.
The wiki’s overview should reference seaweed-as-a-Cd-pathway alongside the established rice-as-an-iAs-pathway and cocoa-as-a-Cd-pathway findings; the three together are the major non-obvious commodity-level Cd and As contributors that the wiki has identified.
Provisional status
This synthesis was established 2026-05-16 on three anchor sources and is provisional pending integration of US-market commercial-product surveys and species-level breakouts. The EFSA regulatory anchor is durable; the magnitude numbers are robust across three independent geographic regions; the biological-mechanism claim is supported by the algal-physiology literature and does not depend on any single source. Resynthesis triggers per CLAUDE.md Part 9 fire on the next two independent A-tier sources confirming or contradicting either the magnitude or the surveillance-blind-spot finding.
Peer review state
This synthesis claim has not yet been evaluated by external reviewers. Verdicts will be added here as named domain experts (listed at curators) complete their review. The verdict log is data/peer-review/<reviewer-slug>.jsonl and is part of the public corpus.
| Reviewer | Verdict | Review date | Notes |
|---|---|---|---|
| no reviews yet |
The Heavy Metal Index publishes synthesis claims before external review completes, with the review state visibly tracked. This is the same model Cochrane uses for its protocols: the claim is published, the review accumulates over time, and the credibility of the claim is partly the cumulative result of visible review.
Page history
The five most recent substantive edits to this page. The full version history lives in git; when DOI minting comes online (see schema docs), each entry below will also link to a version-pinned DataCite DOI.